✦ LIBER ✦

A risk-adapted strategy of radiotherapy or cisplatin-based chemotherapy in stage II seminoma

✍ Scribed by Domont, Julien; Massard, Christophe; Patrikidou, Anna; Bossi, Alberto; de Crevoisier, Renaud; Rose, Mathieu; Wibault, Pierre; Fizazi, Karim

Book ID: 122395464
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 785 KB
Volume: 31
Category: Article
ISSN: 1078-1439
DOI: 10.1016/j.urolonc.2011.04.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cyclophosphamide, doxorubicin, vincristi

Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy

✍ Augustinus D.G Krol; Henriëtte W.A Berenschot; Dew Doekharan; Sonja Henzen-Logma 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 97 KB

A Risk-adapted Study of Cisplatin and Et

A Risk-adapted Study of Cisplatin and Etoposide, with or Without Ifosfamide, in Patients with Metastatic Seminoma: Results of the GETUG S99 Multicenter Prospective Study

✍ Fizazi, Karim; Delva, Rémi; Caty, Armelle; Chevreau, Christine; Kerbrat, Pierre; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 337 KB

A phase II study of irinotecan plus cisp

A phase II study of irinotecan plus cisplatin for patients with advanced stage IIIB or IV NSCLC previously treated with nonplatinum-based chemotherapy

✍ Heung T. Kim; Ji-Youn Han; Dae H. Lee; Jong H. Chun; Hong G. Lee; Jae J. Lee; Hy 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Rapidly alternating radiotherapy and hig

Rapidly alternating radiotherapy and high dose cisplatin chemotherapy in stage IIIB non-small cell lung cancer: Results of a phase I/II study

✍ David R. Gandara; Frank H. Valone; Edith A. Perez; Albert B. Deisseroth; Mack Ro 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 709 KB

P-601 A phase II randomized study of tho

P-601 A phase II randomized study of thoracic radiotherapy with or without weekly docetaxel following docetaxel-cisplatin induction chemotherapy in unresectable stage IIIA-IIIB non-small cell lung cancer

✍ Manegold, Christian; Ramlau, Rodryg; Scagliotti, Giorgio V.; Buchholz, Edith; Sz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Rapidly alternating combination of cispl

Rapidly alternating combination of cisplatin-based chemotherapy and hyperfractionated accelerated radiotherapy in split course for stage IIIA and stage IIIB non-small cell lung cancer: Results of a phase I–II study by the GOTHA group

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 131 KB